Recent advances in gene therapy for lysosomal storage disorders

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Lysosomal storage disorders (LSDs) are genetic conditions causing metabolic dysfunction due to enzyme deficiencies.
• Substrate accumulation within lysosomes leads to diverse, tissue-specific symptoms and disabilities.
• LSDs are prime candidates for gene therapy due to the potential for significant clinical impact with limited gene delivery.

Purpose of the Study:

• To review recent innovations in gene therapy for LSDs.
• To discuss existing clinical limitations and barriers to effective gene therapy for LSDs.
• To foster understanding and further development in the field of LSD gene therapy.

Main Methods:

• Review of recent scientific literature and clinical trial data on gene therapy for LSDs.
• Analysis of advancements in gene delivery systems and therapeutic strategies.
• Identification and discussion of biological and immunological challenges in LSD gene therapy.

Main Results:

• Significant progress has been made in developing gene therapy approaches for LSDs, including initial human trials.
• Understanding of immune responses to gene therapy has improved, informing future trial design.
• Key challenges remain, including overcoming the blood-brain barrier for neuropathic LSDs and other biological obstacles.

Conclusions:

• Gene therapy holds substantial promise for treating LSDs, with recent advancements showing encouraging results.
• Addressing immunological and biological barriers, particularly the blood-brain barrier, is crucial for successful clinical translation.
• Continued research and development are essential to overcome limitations and realize the full potential of gene therapy for LSDs.